RT @_connectedcare: SELECT-PsA2 group refractory to prior bDMARD therapy UPA - useful oral JAKi option in Psoriatic Art
Tweet Content
SELECT-PsA2 group refractory to prior bDMARD therapy
UPA - useful oral JAKi option in Psoriatic Arthritis
Safety consistent with what we know from RA. More Sfx at 30mg. No clear VTE signal
#ACR20 https://t.co/XpprRprugI
Show on Archive Page
On
Display in Search Results
On